DEVELOPMENT BY DESIGN Trademark

Trademark Overview


On Wednesday, January 13, 2016, a trademark application was filed for DEVELOPMENT BY DESIGN with the United States Patent and Trademark Office. The USPTO has given the DEVELOPMENT BY DESIGN trademark a serial number of 86873967. The federal status of this trademark filing is PARTIAL SECTION 8 ACCEPTED as of Friday, June 7, 2024. This trademark is owned by Hovione Scientia Limited. The DEVELOPMENT BY DESIGN trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, and Pharmaceutical Products categories with the following description:

research and development of manufacturing processes for the pharmaceutical industry; research in the field of optimizing manufacturing processes for the pharmaceutical industry

[ Compositions for medical and veterinarian use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; diagnostic preparations for medical purposes; chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and di...

[ Active chemical ingredients for use in the manufacture of pharmaceuticals ]
development by design

General Information


Serial Number86873967
Word MarkDEVELOPMENT BY DESIGN
Filing DateWednesday, January 13, 2016
Status704 - PARTIAL SECTION 8 ACCEPTED
Status DateFriday, June 7, 2024
Registration Number5220043
Registration DateTuesday, June 6, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesresearch and development of manufacturing processes for the pharmaceutical industry; research in the field of optimizing manufacturing processes for the pharmaceutical industry
Goods and Services[ Compositions for medical and veterinarian use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; diagnostic preparations for medical purposes; chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals ]
Goods and Services[ Active chemical ingredients for use in the manufacture of pharmaceuticals ]

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, January 19, 2016
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateFriday, June 7, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateFriday, June 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHovione Scientia Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCork
IE

Party NameHovione Scientia Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCork
IE

Trademark Events


Event DateEvent Description
Thursday, February 18, 2016ASSIGNED TO EXAMINER
Saturday, January 16, 2016NEW APPLICATION ENTERED
Tuesday, January 19, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 25, 2016NON-FINAL ACTION WRITTEN
Thursday, February 25, 2016NON-FINAL ACTION E-MAILED
Thursday, February 25, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 26, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, September 25, 2016FINAL REFUSAL WRITTEN
Sunday, September 25, 2016FINAL REFUSAL E-MAILED
Sunday, September 25, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 26, 2016SUBSEQUENT FINAL REFUSAL WRITTEN
Monday, September 26, 2016SUBSEQUENT FINAL EMAILED
Monday, September 26, 2016NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Thursday, March 23, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 27, 2017AMENDMENT FROM APPLICANT ENTERED
Monday, March 27, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, March 27, 2017EXAMINERS AMENDMENT E-MAILED
Monday, March 27, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 27, 2017EXAMINER'S AMENDMENT ENTERED
Monday, March 27, 2017APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, April 25, 2017ASSIGNED TO LIE
Thursday, May 4, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 6, 2017REGISTERED-SUPPLEMENTAL REGISTER
Monday, June 6, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 8, 2023TEAS SECTION 8 RECEIVED
Tuesday, November 21, 2023POST REGISTRATION ACTION MAILED - SEC. 8
Tuesday, November 21, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 21, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, June 7, 2024REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Friday, June 7, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED